Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Sees Large Decline in Short Interest

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 393,700 shares, a drop of 20.5% from the February 13th total of 495,100 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 3,937.0 days.

Kyowa Kirin Price Performance

Shares of OTCMKTS:KYKOF remained flat at $13.65 during midday trading on Wednesday. Kyowa Kirin has a 1-year low of $12.32 and a 1-year high of $22.21. The business’s 50-day moving average is $14.06 and its 200 day moving average is $16.54.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.